Golden Prospect Precious Metals Ltd Director/PDMR Shareholding

RNS Number : 0763Q

Golden Prospect Precious Metals Ltd

13 December 2024

 

13 December 2024

Golden Prospect Precious Metals Limited (the "Company")

Director/PDMR shareholding

The Company wishes to announce in accordance with DTR 3.1 and Article 19 of the UK Market Abuse Regulation the following dealing in the Company's ordinary shares of no par value by persons discharging managerial responsibility:

 

Details of the person discharging managerial responsibilities/person closely associated
Name	Robert Crayfourd
Reason for the notification
Position/status	Investment Manager - Manulife | CQS Investment Management
Initial Notification Amendment	Initial Notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Golden Prospect Precious Metals Limited
LEI	549300SD5YLRIUMG395
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial  instrument, type  of instrument Identification code	Ordinary shares   ISIN: GG00B1G9T992
Nature of the transaction	Subscription Rights Issue
Price(s) and volume(s)	Price(s) Volume(s) GBP 0.3594 49,948
Aggregated information - Aggregated volume - Price	49,948 £17,951.31
Date of the transaction	11 December 2024
Place of the transaction	LONDON STOCK EXCHANGE, (XLON)
Additional Information

This announcement is made in accordance with the requirements of the UK Market Abuse Regulation ("MAR") and the Company confirms that the PDMR's notification obligations under MAR have also been satisfied.

Enquiries:

Apex Administration (Guernsey) Limited

James Taylor                                                                [phone]

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHBDBDDIBBDGSX